Clinical & Translational Oncology

Papers
(The TQCC of Clinical & Translational Oncology is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
The new function of circRNA: translation109
Covid-19 transmission, outcome and associated risk factors in cancer patients at the first month of the pandemic in a Spanish hospital in Madrid71
Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas69
Exosome-transmitted lncRNA PCGEM1 promotes invasive and metastasis in gastric cancer by maintaining the stability of SNAI143
A signature of 14 immune-related gene pairs predicts overall survival in gastric cancer42
CDK1 promotes the stemness of lung cancer cells through interacting with Sox241
SEOM clinical guidelines for the treatment of head and neck cancer (2020)39
Ferroptosis: an iron-dependent cell death form linking metabolism, diseases, immune cell and targeted therapy37
Immune cell infiltration features and related marker genes in lung cancer based on single-cell RNA-seq33
Cyclin-dependent kinase (CDK) inhibitors in solid tumors: a review of clinical trials33
Inhibitory effect of polyphenols (phenolic acids, lignans, and stilbenes) on cancer by regulating signal transduction pathways: a review32
Comprehensive assessment of multiple tryptophan metabolites as potential biomarkers for immune checkpoint inhibitors in patients with non-small cell lung cancer31
Tumor microenvironment in triple-negative breast cancer: the correlation of tumor-associated macrophages and tumor-infiltrating lymphocytes30
A natural flavonoid, apigenin isolated from Clerodendrum viscosum leaves, induces G2/M phase cell cycle arrest and apoptosis in MCF-7 cells through the regulation of p53 and caspase-cascade pathway30
Anti-PD-1/L1-associated immune-related adverse events as harbinger of favorable clinical outcome: systematic review and meta-analysis29
Prognostic impact of Claudin 18.2 in gastric and esophageal adenocarcinomas28
Apolipoproteins, as the carrier proteins for lipids, are involved in the development of breast cancer27
Traditional Chinese medicine reverses cancer multidrug resistance and its mechanism27
The emerging roles of exosomal circRNAs in diseases26
CDKN2A inhibits cell proliferation and invasion in cervical cancer through LDHA-mediated AKT/mTOR pathway26
Targeting GLS1 to cancer therapy through glutamine metabolism25
Curcumin suppresses tumor growth of gemcitabine-resistant non-small cell lung cancer by regulating lncRNA-MEG3 and PTEN signaling25
Tumor microenvironment, immune response and post-radiotherapy tumor clearance25
Multidisciplinary consensus statement on the clinical management of patients with pancreatic cancer24
Renin-angiotensin system and cancer: epidemiology, cell signaling, genetics and epigenetics24
Urinary microRNAs expression in prostate cancer diagnosis: a systematic review24
Programmable and multi-targeted CARs: a new breakthrough in cancer CAR-T cell therapy24
SEOM Clinical Guideline of management of soft-tissue sarcoma (2020)24
Complex roles of discoidin domain receptor tyrosine kinases in cancer23
SEOM clinical guidelines for pancreatic and biliary tract cancer (2020)22
SEOM clinical guideline in ovarian cancer (2020)22
miR-143-3p inhibits proliferation and invasion of hepatocellular carcinoma cells by regulating its target gene FGF122
Social support, coping strategies and sociodemographic factors in women with breast cancer22
Hyperbaric oxygen and radiation therapy: a review21
MiR-495-3p and miR-143-3p co-target CDK1 to inhibit the development of cervical cancer21
SEOM clinical guideline for the management of cutaneous melanoma (2020)21
ST8SIA1 inhibition sensitizes triple negative breast cancer to chemotherapy via suppressing Wnt/β-catenin and FAK/Akt/mTOR20
Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for tre19
miR-22 suppresses cell viability and EMT of ovarian cancer cells via NLRP3 and inhibits PI3K/AKT signaling pathway19
ADMA mediates gastric cancer cell migration and invasion via Wnt/β-catenin signaling pathway19
RUNX1-activated upregulation of lncRNA RNCR3 promotes cell proliferation, invasion, and suppresses apoptosis in colorectal cancer via miR-1301-3p/AKT1 axis in vitro and in vivo19
FAM83H overexpression predicts worse prognosis and correlates with less CD8+ T cells infiltration and Ras-PI3K-Akt-mTOR signaling pathway in pancreatic cancer19
Research progress of tumor microenvironment and tumor-associated macrophages18
Multidisciplinary consensus on the criteria for fertility preservation in cancer patients18
The role of macrophages during breast cancer development and response to chemotherapy18
hsa_circ_0121582 inhibits leukemia growth by dampening Wnt/β-catenin signaling18
SEOM clinical guidelines for the treatment of advanced prostate cancer (2020)18
Incidence of venous thromboembolic events in cancer patients receiving immunotherapy: a single-institution experience17
ABVD and BEACOPP regimens’ effects on fertility in young males with Hodgkin lymphoma17
Randomized placebo-controlled phase II trial of high-dose melatonin mucoadhesive oral gel for the prevention and treatment of oral mucositis in patients with head and neck cancer undergoing radiation 17
Multidisciplinary consensus on optimising the detection of NTRK gene alterations in tumours16
The effects of human sera conditioned by high-intensity exercise sessions and training on the tumorigenic potential of cancer cells16
MiR-92 overexpression suppresses immune cell function in ovarian cancer via LATS2/YAP1/PD-L1 pathway16
Circ_03955 promotes pancreatic cancer tumorigenesis and Warburg effect by targeting the miR-3662/HIF-1α axis16
The correlation of 18F-FDG PET/CT metabolic parameters, clinicopathological factors, and prognosis in breast cancer16
Trends of incidence, mortality and survival of multiple myeloma in Spain. A twenty-three-year population-based study16
Novel combinatorial strategies for boosting the efficacy of immune checkpoint inhibitors in advanced breast cancers16
PSMA-PET and micro-ultrasound potential in the diagnostic pathway of prostate cancer15
Multidisciplinary consensus on cancer management during pregnancy15
Clinical significance of expression level of CX3CL1–CX3CR1 axis in bone metastasis of lung cancer15
SEOM clinical guidelines for the treatment of malignant pleural mesothelioma (2020)15
Oligo metastatic renal cell carcinoma: stereotactic body radiation therapy, if, when and how?15
A seven-nuclear receptor-based prognostic signature in breast cancer15
Human umbilical cord mesenchymal stem cell-derived exosomes carrying hsa-miRNA-128-3p suppress pancreatic ductal cell carcinoma by inhibiting Galectin-314
Oxymatrine reduces expression of programmed death-ligand 1 by promoting DNA demethylation in colorectal cancer cells14
PILE: a candidate prognostic score in cancer patients treated with immunotherapy14
PARP inhibitor niraparib as a radiosensitizer promotes antitumor immunity of radiotherapy in EGFR-mutated non-small cell lung cancer14
Identification of a novel cancer microbiome signature for predicting prognosis of human breast cancer patients14
Propofol inhibited gastric cancer proliferation via the hsa-miR-328-3p/STAT3 pathway14
Circular RNAs as important players in human gastric cancer14
Stereotactic ablative radiotherapy in castration-resistant prostate cancer patients with oligoprogression during androgen receptor-targeted therapy14
Cytomegalovirus infection as an underestimated trigger for checkpoint inhibitor-related pneumonitis in lung cancer: a retrospective study14
Cellular immunotherapy: a clinical state-of-the-art of a new paradigm for cancer treatment13
DDAB cationic lipid-mPEG, PCL copolymer hybrid nano-carrier synthesis and application for delivery of siRNA targeting IGF-1R into breast cancer cells13
Identification of a novel immune prognostic model in gastric cancer13
The role of brachytherapy (interventional radiotherapy) for primary and/or recurrent vulvar cancer: a Gemelli Vul.Can multidisciplinary team systematic review13
Influence of glioblastoma contact with the subventricular zone on survival and recurrence patterns13
Survival outcomes and prognostic factors of endometrial stromal sarcoma and undifferentiated uterine sarcoma13
Update of the recommendations for the determination of biomarkers in colorectal carcinoma: National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology13
miR-144-3p increases radiosensibility of gastric cancer cells by targeting inhibition of ZEB113
UCHL3 promotes aerobic glycolysis of pancreatic cancer through upregulating LDHA expression13
Nerve growth factor orchestrates NGAL and matrix metalloproteinases activity to promote colorectal cancer metastasis13
Role of adjuvant radiotherapy in atypical (WHO grade II) and anaplastic (WHO grade III) meningiomas: a systematic review13
Evaluating anti-tumor activity of palbociclib plus radiation in anaplastic and radiation-induced meningiomas: pre-clinical investigations13
TWIST1 upregulation affects E-cadherin expression in brain metastases13
Study on effects of miR-141-3p in proliferation, migration, invasion and apoptosis of colon cancer cells by inhibiting Bcl212
Dynamics of clinical biomarkers as predictors of immunotherapy benefit in metastatic melanoma patients12
Circular RNA circHIPK3 modulates prostate cancer progression via targeting miR-448/MTDH signaling12
Role of the parasympathetic nervous system in cancer initiation and progression12
IFN-γ inhibits ovarian cancer progression via SOCS1/JAK/STAT signaling pathway12
Radiation-induced lymphopenia: the main aspects to consider in immunotherapy trials for endometrial and cervical cancer patients12
Is there a role for chemotherapy and radiation in the treatment of patients with low-grade myofibroblastic sarcoma?12
Dynamic biomarkers indicate the immunological benefits provided by Ganoderma spore powder in post-operative breast and lung cancer patients12
Physio-pathological effects of m6A modification and its potential contribution to melanoma12
LncRNA DCST1-AS1 downregulates miR-29b through methylation in glioblastoma (GBM) to promote cancer cell proliferation12
Long-term outcomes of induction chemotherapy followed by chemoradiotherapy vs chemoradiotherapy alone as treatment of unresectable head and neck cancer: follow-up of the Spanish Head and Neck Cancer G12
0.022535800933838